Literature DB >> 25239141

Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2.

Jun Zhang1, Janet K Sawyer1, Stephanie M Marshall1, Kathryn L Kelley1, Matthew A Davis1, Martha D Wilson1, J Mark Brown1, Lawrence L Rudel2.   

Abstract

RATIONALE: Cholesterol esters (CE), especially cholesterol oleate, generated by hepatic and intestinal sterol O-acyltransferase 2 (SOAT2) play a critical role in cholesterol homeostasis. However, it is unknown whether the contribution of intestine-derived CE from SOAT2 would have similar effects in promoting atherosclerosis progression as for liver-derived CE.
OBJECTIVE: To test whether, in low-density lipoprotein receptor null (LDLr(-/-)) mice, the conditional knockout of intestinal SOAT2 (SOAT2(SI-/SI-)) or hepatic SOAT2 (SOAT2(L-/L-)) would equally limit atherosclerosis development compared with the global deletion of SOAT2 (SOAT2(-/-)). METHODS AND
RESULTS: SOAT2 conditional knockout mice were bred with LDLr(-/-) mice creating LDLr(-/-) mice with each of the specific SOAT2 gene deletions. All mice then were fed an atherogenic diet for 16 weeks. SOAT2(SI-/SI-)LDLr(-/-) and SOAT2(-/-)LDLr(-/-) mice had significantly lower levels of intestinal cholesterol absorption, more fecal sterol excretion, and lower biliary cholesterol levels. Analysis of plasma LDL showed that all mice with SOAT2 gene deletions had LDL CE with reduced percentages of cholesterol palmitate and cholesterol oleate. Each of the LDLr(-/-) mice with SOAT2 gene deletions had lower accumulations of total cholesterol and CE in the liver compared with control mice. Finally, aortic atherosclerosis development was significantly lower in all mice with global or tissue-restricted SOAT2 gene deletions. Nevertheless, SOAT2(-/-)LDLr(-/-) and SOAT2(L-/L-)LDLr(-/-) mice had less aortic CE accumulation and smaller aortic lesions than SOAT2(SI-/SI-)LDLr(-/-) mice.
CONCLUSIONS: SOAT2-derived CE from both the intestine and liver significantly contribute to the development of atherosclerosis, although the CE from the hepatic enzyme appeared to promote more atherosclerosis development.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; cholesterol esters; molecular biology; sterol O-acyltransferase 2

Mesh:

Substances:

Year:  2014        PMID: 25239141      PMCID: PMC4209196          DOI: 10.1161/CIRCRESAHA.115.304378

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  26 in total

1.  Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2.

Authors:  Ryan E Temel; Richard G Lee; Kathryn L Kelley; Matthew A Davis; Ramesh Shah; Janet K Sawyer; Martha D Wilson; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

2.  ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice.

Authors:  Richard G Lee; Ramesh Shah; Janet K Sawyer; Robert L Hamilton; John S Parks; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2005-04-01       Impact factor: 5.922

3.  Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization.

Authors:  Heather M Alger; J Mark Brown; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Mark C Willingham; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

4.  Cholesterol esterification by ACAT2 is essential for efficient intestinal cholesterol absorption: evidence from thoracic lymph duct cannulation.

Authors:  Tam M Nguyen; Janet K Sawyer; Kathryn L Kelley; Matthew A Davis; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2011-11-01       Impact factor: 5.922

5.  Cholesteryl esters associated with acyl-CoA:cholesterol acyltransferase predict coronary artery disease in patients with symptoms of acute coronary syndrome.

Authors:  Chadwick D Miller; Michael J Thomas; Brian Hiestand; Michael P Samuel; Martha D Wilson; Janet Sawyer; Lawrence L Rudel
Journal:  Acad Emerg Med       Date:  2012-06       Impact factor: 3.451

6.  Tissue-specific knockouts of ACAT2 reveal that intestinal depletion is sufficient to prevent diet-induced cholesterol accumulation in the liver and blood.

Authors:  Jun Zhang; Kathryn L Kelley; Stephanie M Marshall; Matthew A Davis; Martha D Wilson; Janet K Sawyer; Robert V Farese; J Mark Brown; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2012-03-29       Impact factor: 5.922

7.  Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.

Authors:  Thomas A Bell; J Mark Brown; Mark J Graham; Kristina M Lemonidis; Rosanne M Crooke; Lawrence L Rudel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-04       Impact factor: 8.311

Review 8.  Acyl-coenzyme A:cholesterol acyltransferases.

Authors:  Ta-Yuan Chang; Bo-Liang Li; Catherine C Y Chang; Yasuomi Urano
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-13       Impact factor: 4.310

9.  Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss.

Authors:  J Mark Brown; Thomas A Bell; Heather M Alger; Janet K Sawyer; Thomas L Smith; Kathryn Kelley; Ramesh Shah; Martha D Wilson; Matthew A Davis; Richard G Lee; Mark J Graham; Rosanne M Crooke; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

Review 10.  LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat.

Authors:  Chiara Degirolamo; Gregory S Shelness; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2008-11-22       Impact factor: 5.922

View more
  14 in total

1.  Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss.

Authors:  Manya Warrier; Jun Zhang; Kanwardeep Bura; Kathryn Kelley; Martha D Wilson; Lawrence L Rudel; J Mark Brown
Journal:  Lipids       Date:  2016-01-04       Impact factor: 1.880

2.  Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.

Authors:  Adam M Lopez; Kenneth S Posey; Stephen D Turley
Journal:  Biochem Biophys Res Commun       Date:  2014-10-18       Impact factor: 3.575

3.  Ontogenesis and Modulation of Intestinal Unesterified Cholesterol Sequestration in a Mouse Model of Niemann-Pick C1 Disease.

Authors:  Adam M Lopez; Charina M Ramirez; Anna M Taylor; Ryan D Jones; Joyce J Repa; Stephen D Turley
Journal:  Dig Dis Sci       Date:  2019-07-17       Impact factor: 3.199

4.  Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice.

Authors:  John T Melchior; John D Olson; Kathryn L Kelley; Martha D Wilson; Janet K Sawyer; Kerry M Link; Lawrence L Rudel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-30       Impact factor: 8.311

5.  New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.

Authors:  Taichi Ohshiro; Masaki Ohtawa; Tohru Nagamitsu; Daisuke Matsuda; Hiroaki Yagyu; Matthew A Davis; Lawrence L Rudel; Shun Ishibashi; Hiroshi Tomoda
Journal:  J Pharmacol Exp Ther       Date:  2015-09-03       Impact factor: 4.030

6.  Impact of loss of SOAT2 function on disease progression in the lysosomal acid lipase-deficient mouse.

Authors:  Adam M Lopez; Jen-Chieh Chuang; Stephen D Turley
Journal:  Steroids       Date:  2017-12-13       Impact factor: 2.668

7.  ACAT-1 gene polymorphism is associated with increased susceptibility to coronary artery disease in Chinese Han population: a case-control study.

Authors:  Yong-Tao Wang; Ying-Hong Wang; Yi-Tong Ma; Zhen-Yan Fu; Yi-Ning Yang; Xiang Ma; Xiao-Mei Li; Dilare Adi; Fen Liu; Bang-Dang Chen
Journal:  Oncotarget       Date:  2017-10-06

8.  Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte.

Authors:  Robert Scott Kiss; Allan Sniderman
Journal:  J Biomed Res       Date:  2017-01-19

9.  Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.

Authors:  Preeti Pathak; Robert N Helsley; Amanda L Brown; Jennifer A Buffa; Ibrahim Choucair; Ina Nemet; Camelia Baleanu Gogonea; Valentin Gogonea; Zeneng Wang; Jose Carlos Garcia-Garcia; Lei Cai; Ryan Temel; Naseer Sangwan; Stanley L Hazen; J Mark Brown
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-04-24       Impact factor: 4.733

10.  Sterol O-Acyltransferase 2 Contributes to the Yolk Cholesterol Trafficking during Zebrafish Embryogenesis.

Authors:  Nai-Yun Chang; Yen-Ju Chan; Shih-Torng Ding; Yen-Hua Lee; Wei-Chun HuangFu; I-Hsuan Liu
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.